Product Details for: Mvasi

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/4ML (25MG/ML)
Single-Dose Vial
351(k) Biosimilar
Mvasi
Rx
002
Injection
Intravenous
400MG/16ML (25MG/ML)
Single-Dose Vial
351(k) Biosimilar
Mvasi
Rx
Proper Name
bevacizumab-awwb
Reference Product Proper Name
bevacizumab
Reference Product Properietary Name
Avastin
BLA Number
761028
Applicant
Amgen Inc.
Original Approval Date
September 14, 2017
Date of First Licensure
RETURN TO SEARCH RESULTS